Cerity Partners LLC Acquires 21,656 Shares of STERIS plc $STE

Cerity Partners LLC lifted its stake in STERIS plc (NYSE:STE) by 28.8% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 96,853 shares of the medical equipment provider’s stock after purchasing an additional 21,656 shares during the period. Cerity Partners LLC’s holdings in STERIS were worth $23,966,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Allworth Financial LP lifted its stake in STERIS by 7.3% in the second quarter. Allworth Financial LP now owns 661 shares of the medical equipment provider’s stock valued at $159,000 after buying an additional 45 shares during the period. Geneos Wealth Management Inc. raised its position in shares of STERIS by 34.9% in the 2nd quarter. Geneos Wealth Management Inc. now owns 174 shares of the medical equipment provider’s stock valued at $42,000 after acquiring an additional 45 shares during the period. Ashton Thomas Private Wealth LLC raised its position in shares of STERIS by 3.5% in the 1st quarter. Ashton Thomas Private Wealth LLC now owns 1,611 shares of the medical equipment provider’s stock valued at $365,000 after acquiring an additional 54 shares during the period. Balefire LLC boosted its stake in STERIS by 5.0% during the 3rd quarter. Balefire LLC now owns 1,128 shares of the medical equipment provider’s stock worth $279,000 after acquiring an additional 54 shares during the last quarter. Finally, Berry Wealth Group LP grew its holdings in STERIS by 5.3% during the second quarter. Berry Wealth Group LP now owns 1,251 shares of the medical equipment provider’s stock valued at $300,000 after purchasing an additional 63 shares during the period. 94.69% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at STERIS

In other STERIS news, VP Renato Tamaro sold 5,036 shares of the business’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $257.55, for a total transaction of $1,297,021.80. Following the sale, the vice president directly owned 5,695 shares of the company’s stock, valued at $1,466,747.25. The trade was a 46.93% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, VP Julia Madsen sold 5,008 shares of the stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $262.00, for a total transaction of $1,312,096.00. Following the transaction, the vice president owned 10,710 shares of the company’s stock, valued at approximately $2,806,020. This represents a 31.86% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 25,044 shares of company stock worth $6,586,218. Insiders own 1.07% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on STE. Wall Street Zen upgraded shares of STERIS from a “buy” rating to a “strong-buy” rating in a report on Sunday, September 14th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a research note on Tuesday, October 14th. Seven analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, STERIS currently has a consensus rating of “Moderate Buy” and a consensus price target of $273.50.

STERIS Stock Down 1.5%

STE stock opened at $256.77 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.37 and a quick ratio of 1.63. The stock has a market capitalization of $25.20 billion, a P/E ratio of 36.89 and a beta of 1.03. STERIS plc has a fifty-two week low of $204.28 and a fifty-two week high of $268.60. The business has a 50-day moving average of $257.52 and a 200-day moving average of $245.77.

STERIS (NYSE:STE) last released its earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 EPS for the quarter, beating the consensus estimate of $2.38 by $0.09. STERIS had a return on equity of 14.43% and a net margin of 12.07%.The firm had revenue of $1.46 billion for the quarter, compared to analysts’ expectations of $1.43 billion. During the same quarter in the previous year, the business posted $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. On average, sell-side analysts anticipate that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, December 18th. Investors of record on Tuesday, November 18th were given a $0.63 dividend. The ex-dividend date of this dividend was Tuesday, November 18th. This represents a $2.52 dividend on an annualized basis and a yield of 1.0%. STERIS’s dividend payout ratio (DPR) is 36.21%.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.